Daily non-political popular news in brief.
UCSF brain tumor vaccine trial shows promising results
04-16-2007 · EurekAlert!A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain has shown promise in preliminary data from a clinical trial at the University of California, San Francisco.
Read more »
Keywords: ucsf, brain, tumor, vaccine, trial, shows, promising, results, show, result
« Previous | Next »
Similar news on "UCSF brain tumor vaccine trial shows promising results":
- Vaccine for brain tumors shows promising results
11-16-2006 · EurekAlert!
A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain, known as glioma, has shown promising results in preliminary data from a clinical trial at UCSF Medical Center.
Similar news · Read more »
- Carnegie Mellon University research shows how sensory-deprived brain compensates
04-17-2007 · EurekAlert!
Whiskers provide a mouse with essential information. These stiff hairs relay sensory input to the brain, which shapes neuronal activity. In a first, studies of this system by Carnegie Mellon scientists show just how well a mouse brain can compensate when limited to sensing the world through one whisker. Published April 4 in the Journal of Neuroscience, the results should help shape future studies of sensory deprivation that results from stroke or traumatic brain injury.
Similar news · Read more »
- Drug study for brain cancer shows promising results
12-13-2007 · EurekAlert!
A clinical study conducted at Henry Ford Hospital on the use of a drug to extend the survival of patients with the most common and aggressive type of brain cancer, has yielded results that were significantly better than expected.
Similar news · Read more »
- Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
06-04-2007 · EurekAlert!
The number of tumor cells circulating in the bloodstream of patients with metastatic, hormone-resistant, prostate cancer can predict how they will do with chemotherapy, according to results of an international trial. The findings, if backed by larger studies, could have important implications for designing personalized treatments for this very dangerous type of prostate cancer, says a Jefferson Medical College researcher and study first author.
Similar news · Read more »
- Rhode Island Hospital study confirms RF ablation effective for treating inoperable lung cancer
03-27-2007 · EurekAlert!
The overall results of a study of 153 patients with inoperable lung cancer show RF ablation to be safe and linked it with promising long-term survival and local tumor progression outcomes when compared to the older treatment method of external beam radiation (EBT). The study appears in the April issue of the journal Radiology.
Similar news · Read more »
- Early promising results in malaria vaccine trial in Mali
01-22-2008 · EurekAlert!
A small clinical trial conducted by an international team of researchers in Mali has found that a candidate malaria vaccine was safe and elicited strong immune responses in the 40 Malian adults who received it. The trial was the first to test this vaccine candidate, which is designed to block the malaria parasite from entering human blood cells, in a malaria-endemic country.
Similar news · Read more »
- Human trial results show excellent safety data, from Geovax's DNA/MVA AIDS vaccines
02-06-2007 · EurekAlert!
GeoVax Labs, Inc. an Atlanta-based biotechnology company, today reported successful early results from two ongoing AIDS prevention Phase I human vaccine trials. Results from the first low-dose trial indicate a good safety profile as well as positive immune responses in human volunteers receiving 1/10th dose of GeoVax's AIDS vaccine. Results from a second larger full-dose trial also indicate a good safety profile in participants.
Similar news · Read more »
- VEGF Trap shows activity in patients with advanced ovarian cancer
06-02-2007 · EurekAlert!
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents. The findings, which are being presented today at the American Society of Clinical Oncology’s annual meeting, may indicate a role for this targeted therapy in women with ovarian cancer who have exhausted all other options.
Similar news · Read more »
- Other highlights in the Oct. 30 JNCI
10-30-2007 · EurekAlert!
Also in the Oct. 30 JNCI -- a cancer-killing virus that may be used to treat metastatic cancer, the risk of second cancers in cervical cancer survivors, a novel trial design that shows which cancer treatments are the most promising, and a review on brain cancer therapies that target normal brain cells too.
Similar news · Read more »
- Brain tumor researchers find their 'niche'
01-16-2007 · EurekAlert!
Brain tumors appear to arise from cancer stem cells (CSCs) that live within microscopic protective "niches" formed by blood vessels in the brain; and disrupting these niches is a promising strategy for eliminating the tumors and preventing them from re-growing, according to results of a study by investigators at St. Jude Children's Research Hospital. CSCs are cells that continually multiply, acting as the source of tumors.
Similar news · Read more »
